Quotient Wealth Partners LLC Sells 467 Shares of Zoetis Inc. (NYSE:ZTS)

Quotient Wealth Partners LLC decreased its stake in shares of Zoetis Inc. (NYSE:ZTS) by 13.1% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 3,095 shares of the company’s stock after selling 467 shares during the quarter. Quotient Wealth Partners LLC’s holdings in Zoetis were worth $504,000 as of its most recent SEC filing.

Other large investors also recently added to or reduced their stakes in the company. Darwin Wealth Management LLC bought a new position in Zoetis in the third quarter worth approximately $31,000. First Personal Financial Services bought a new position in shares of Zoetis during the 3rd quarter worth $33,000. Capital Performance Advisors LLP purchased a new position in shares of Zoetis during the third quarter valued at $33,000. Dunhill Financial LLC raised its holdings in shares of Zoetis by 80.6% in the 3rd quarter. Dunhill Financial LLC now owns 168 shares of the company’s stock valued at $33,000 after purchasing an additional 75 shares in the last quarter. Finally, Fortitude Family Office LLC lifted its holdings in Zoetis by 1,387.5% during the third quarter. Fortitude Family Office LLC now owns 238 shares of the company’s stock worth $46,000 after buying an additional 222 shares during the period. 92.80% of the stock is owned by hedge funds and other institutional investors.

Zoetis Price Performance

Zoetis stock opened at $171.37 on Monday. The firm has a market cap of $77.32 billion, a PE ratio of 32.21, a price-to-earnings-growth ratio of 2.77 and a beta of 0.90. The company has a quick ratio of 2.27, a current ratio of 3.69 and a debt-to-equity ratio of 1.26. Zoetis Inc. has a 52-week low of $144.80 and a 52-week high of $200.53. The company’s 50 day moving average is $169.26 and its two-hundred day moving average is $179.22.

Zoetis Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Tuesday, June 3rd. Investors of record on Monday, April 21st will be issued a $0.50 dividend. The ex-dividend date is Monday, April 21st. This represents a $2.00 annualized dividend and a yield of 1.17%. Zoetis’s dividend payout ratio (DPR) is 37.59%.

Wall Street Analyst Weigh In

A number of analysts have recently weighed in on the stock. UBS Group initiated coverage on shares of Zoetis in a report on Monday, December 9th. They issued a “neutral” rating and a $196.00 price target on the stock. Stifel Nicolaus cut their price target on shares of Zoetis from $210.00 to $180.00 and set a “buy” rating on the stock in a report on Tuesday, January 7th. Leerink Partnrs raised Zoetis to a “strong-buy” rating in a research report on Monday, December 2nd. Leerink Partners started coverage on shares of Zoetis in a research note on Monday, December 2nd. They issued an “outperform” rating and a $215.00 target price for the company. Finally, Morgan Stanley cut their target price on Zoetis from $248.00 to $243.00 and set an “overweight” rating on the stock in a research report on Wednesday, January 29th. One equities research analyst has rated the stock with a hold rating, ten have issued a buy rating and two have given a strong buy rating to the company. According to data from MarketBeat, the stock currently has an average rating of “Buy” and an average target price of $215.00.

About Zoetis

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.